Repair of Anomalous Left Coronary Artery from Pulmonary Artery (ALCAPA) beyond Infancy
AbstractBetween January 2002 and December 2012, five patients (4 female) underwent corrective surgery for anomalous left coronary artery from pulmonary artery (ALCAPA). They were older than 1 year (range, 3-56 years). One of the 2 patients younger than 10 years had presented with congestive heart failure, and the other had experienced repeated episodes of lower respiratory tract infection since childhood. Of the remaining 3 adult patients, 2 had experienced angina with effort, and 1 patient had had repeated respiratory tract infections since childhood, with mild dyspnea on effort of New York Heart Association (NYHA) class II. Three patients had the anomalous left coronary artery implanted directly into the ascending aorta via coronary-button transfer, and 2 patients underwent coronary artery bypass with obliteration of the left main ostium. Two patients underwent concomitant mitral valve repair procedures, and 1 patient underwent direct closure of a perimembranous ventricular septal defect. Four patients survived the surgery, and 1 patient died because of a persistently low cardiac output. Follow-up times ranged from 3 months to 4 years. All survivors are in NYHA class I and have left ventricular ejection fractions of 45% to 60%, with moderate (n = 1), mild (n = 1), or no (n = 2) mitral insufficiency. We conclude that a few naturally selected patients with ALCAPA do survive beyond infancy and can undergo establishment of 2 coronary systems with satisfactory results.
Abbot ME. 1908. Congenital heart disease. In: Osler W, ed. Modern medicine: its theory and practice. Philadelphia, PA: Lea and Febiger. p 420-1.nAkbari J, Theodore S, Krishnamanohar SR, Neelakandhan KS. 2007. Pulmonary hypertension alters natural history of anomalous left coronary artery. Asian Cardiovasc Thorac Ann 15:23-4.nAli WB, Metton O, Roubertie F, et al. 2009. Anomalous origin of the left coronary artery from the pulmonary artery: late results with special attention to the mitral valve. Eur J Cardiothorac Surg 36:244-9.nBergmann O, Bhardwaj RD, Bernard S, et al. 2009. Evidence for cardiomyocyte renewal in humans. Science 324:98-102.nBland EF, White PD, Garland J. 1933. Congenital anomalies of the coronary arteries. Report of an unusual case associated with cardiac hypertrophy. Am Heart J 8:787-801.nBrown JW, Ruzmetov M, Parent JJ, Rodefeld MD, Turrentine MW. 2008. Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin of the left coronary artery from the pulmonary artery? J Thorac Cardiovasc Surg 136:743-8.nCollins N, Colman J, Benson L, Hansen M, Merchant N, Horlick E. 2007. Successful percutaneous treatment of anomalous left coronary artery from pulmonary artery. Int J Cardiol 122:e29-31.nCooley DA, Hallman GL, RD Bloodwell. 1966. Definitive surgical treatment of anomalous origin of the left coronary artery from pulmonary artery: indications and results. J Thorac Cardiovasc Surg 52:798-808.nDodge-Khatami A, Mavroudis C, Backer CL. 2002. Anomalous origin of left coronary artery from the pulmonary artery: collective review of surgical therapy. Ann Thorac Surg 74:946-55.nFierens C, Budts W, Denef B, Van De Werf F. 2000. A 72 year old woman with ALCAPA. Heart 83:e2.nIsomatsu Y, Imai Y, Shin;oka T, Aoki M, Iwata Y. 2001. Surgical intervention for anomalous origin of the left coronary artery from the pulmonary artery: the Tokyo experience. J Thorac Cardiovasc Surg 121:792-7.nLim JY, Chung CH, Ma DS, Lee SH. 2011. A 69-year-old woman with anomalous origin of left coronary artery from the pulmonary artery: surgical repair using a trap-door flap. Korean J Thorac Cardiovasc Surg 44:358-60.nMoodie DS, Fyfe D, Gill, et al. 1983. Anomalous origin of the left coronary artery from the pulmonary artery (Bland-White-Garland syndrome) in adult patients: long-term follow-up after surgery. Am Heart J 106:381-8.nNeches WH, Mathews RA, Park SC, et al. 1974. Anomalous origin of the left coronary artery from the pulmonary artery. A new method of surgical repair. Circulation 50:582-7.nRaghuram AR, Krishnan R, Kumar S. 2004. Anomalous left coronary artery from pulmonary artery in an adult. Ind J Thorac Cardiovasc Surg.20: 213-15.nSabiston DC Jr, Neil CA, Taussig HB. 1960. The direction of blood flow in anomalous left coronary artery arising from the pulmonary artery. Circulation 22:591-7.nSchwartz ML, Jonas RA, Colan SD. 1997. Anomalous origin of the left coronary artery from the pulmonary artery: recovery of left ventricular function after dual coronary repair. J Am Coll Cardiol 30:547-53.nShivalker B, Borgers M, Daenen W, Gewillig M, Flameng W. 1994. ALCAPA syndrome: an example of chronic myocardial hypoperfusion? J Am Coll Cardiol 23:772-8.nTakeuchi S, Imamura S, Katsumoto K, et al. 1979. New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg 78:7-11.nWesselhoeft H, Fawcett JS, Johnson AL. 1968. Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation 38:403-25.nYau JM, Singh R, Halpern EJ. Fischman D. 2011. Anomalous origin of the left coronary artery from the pulmonary artery in adults: a comprehensive review of 151 adult cases and a new diagnosis in a 53-year-old woman. Clin Cardiol 34;4:204-10.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).